2025-03-31T16:39:29Z
2025-03-31T16:39:29Z
2021-02-22
2025-03-31T16:39:29Z
Background: Offspring of patients diagnosed with bipolar disorder and schizophrenia (Off-BDSZ) have a high genetic risk of developing a mental illness. The aim of this project is to develop and investigate the efficacy of an intervention aimed at this population, based on the concept of cognitive reserve. Methods: This is a multicenter randomized trial with an experimental test-retest design study with control group. Two groups will be included: a community comparison group (CC) and a Off-BDSZ group. A total of 108 Off-BDSZ and 65 CC aged between 6 and 25 years will be recruited. Off-BDSZ participants will be randomized to receive either Cognitive Reserve EnhAncement ThErapy (CREATE) (n=54), or a supportive approach (n=54). The CC group will be assessed at baseline. The duration of the intervention will be 3 months, with 12 weekly group sessions. The primary outcome will be the improvement in CR measured according to change in the Cognitive Reserve Assessment Scale in Health (CRASH) and Cognitive Reserve scale for Adolescents (CORE-A). All participants will be blindly evaluated using clinical, cognitive and neuroimaging measures at baseline, at three months (after the psychological intervention), and at twelve-month follow-up after treatment completion. Discussion: The results will provide insight into whether the CREATE-Offspring version may enhance cognitive reserve (CR) in child, adolescent and young adult Off-BDSZ as well as advance knowledge about changes in clinical manifestations, neuropsychological performance and brain structure and function associated with improving CR. This novel and cost-effective intervention represents an advance in the framework of preventive interventions in mental health.
Artículo
Versión aceptada
Inglés
Esquizofrènia; Genètica; Trastorn bipolar; Cognició; Malalties mentals; Schizophrenia; Genetics; Manic-depressive illness; Cognition; Mental illness
Elsevier España
Versió postprint del document publicat a: https://doi.org/10.1016/j.rpsm.2021.02.003
Revista de Psiquiatria y Salud Mental, 2021, vol. 16, num.3, p. 184-191
https://doi.org/10.1016/j.rpsm.2021.02.003
cc-by-nc-nd (c) Sociedad Española de Psiquiatría y Sociedad Española de Psiquiatría Biológica, 2021
http://creativecommons.org/licenses/by-nc-nd/4.0/
ISGlobal - Institut de Salut Global de Barcelona [61310]
Medicina [2855]